THMO Forecast


Bullish Case: With ongoing advances in BAT research and potential breakthroughs (30%), there may be significant opportunities for THMO to capitalize on new obesity treatments, pushing the stock upward.


Bearish Case: THMO showing a significant decline (99.7% over ten years) with current bearish AI forecast and low probability of recovery suggests high risk of further drops without positive catalysts.


Potential Outcomes:

1. Research breakthrough (30%), price spike.

2. Failed new treatment (25%), decline.

3. Prolonged stagnancy (45%), minimal change. Reflecting past stats, short-term spike possible, long-term decline likely.


Trading Oracle: Exploit short-term volatility with Helium Long Volatility debit spreads. Bearish outlook; short-term focus around upcoming research announcements. Prepare for rapid entries/exits to capitalize on spikes or drops.


June 27, 2024


ThermoGenesis Forecast

THMO      ThermoGenesis












Become a more profitable investor with AI optimized trading strategies






×

Chat with THMO


 Ask any question about THMO!